Burkitt's lymphoma medical therapy: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Burkitt's lymphoma}} | {{Burkitt's lymphoma}} | ||
{{CMG}} | {{CMG}}; {{AE}} {{AS}} | ||
==Overview== | ==Overview== | ||
==Medical Therapy== | ==Medical Therapy== | ||
* Drug Regimen: CODOX-M-[[Cyclophosphamide]], {{and}} [[Vincristine]], {{and}} [[Doxorubicin]], {{and}} [[Methotrexate]] | |||
* Drug Regimen: IVAC – (given after or alternated with CODOX-M)[[Ifosfamide]] {{plus}} [[Mesna]], {{and}} [[Etoposide]], {{and}} [[Cytarabine]] | |||
Read more: http://www.cancer.ca/en/cancer-information/cancer-type/non-hodgkin-lymphoma/non-hodgkin-lymphoma/types-of-nhl/burkitt-lymphoma/?region=on#ixzz3n44mw14b | |||
===Chemotherapy=== | ===Chemotherapy=== | ||
* [[cyclophosphamide]] | * [[cyclophosphamide]] | ||
| Line 24: | Line 28: | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Hematology]] | [[Category:Hematology]] | ||
[[Category:Types of cancer]] | [[Category:Types of cancer]] | ||
Revision as of 19:54, 28 September 2015
|
Burkitt's lymphoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Burkitt's lymphoma medical therapy On the Web |
|
American Roentgen Ray Society Images of Burkitt's lymphoma medical therapy |
|
Risk calculators and risk factors for Burkitt's lymphoma medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sowminya Arikapudi, M.B,B.S. [2]
Overview
Medical Therapy
- Drug Regimen: CODOX-M-Cyclophosphamide, AND Vincristine, AND Doxorubicin, AND Methotrexate
- Drug Regimen: IVAC – (given after or alternated with CODOX-M)Ifosfamide PLUS Mesna, AND Etoposide, AND Cytarabine
Chemotherapy